Type 2 diabetes: trials for referral

Where the open trials are

Type a city to sort by distance. The distance is worked out in your browser; the city is not sent anywhere.

Registry facts, one per line, newest first.

• 2 Nov 2026

  Opened for recruitment

  AMBITION 1: A research study investigating how well zenagamtide lowers blood sugar and body weight compared to placebo in people with type 2 diabetes treated with diet and exercise.

  2026-525470-18-00 · Phase 3 · Poland, Romania, Slovakia

  Source: EU CTIS
• 5 Nov 2026

  Opened for recruitment

  Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes

  NCT07866066 · Phase 3 · Canada, United States

  Source: ClinicalTrials.gov
• 5 Nov 2026

  New in the registry

  A Nurse-Led Personalized Self-Management Counseling Intervention to Improve Medication Adherence and Glycemic Control in Adults With Type 2 Diabetes: A Randomized Controlled Trial

  NCT07920042 · No phase · Iraq

  Source: ClinicalTrials.gov
• 5 Nov 2026

  New in the registry

  RESIST! Blood-flow Restriction Resistance Training for Improving Insulin Sensitivity in Type 2 Diabetes

  NCT04222231 · No phase · Germany

  Source: ClinicalTrials.gov
• 5 Nov 2026

  Opened for recruitment

  Effect of 4-7-8 Breathing Technique on Pain and Anxiety During Electromyography in Diabetic Neuropathy

  NCT07702175 · No phase

  Source: ClinicalTrials.gov
• 5 Nov 2026

  New in the registry

  LEANDIP: Lean Diabetes in Asian Indians

  NCT07918170 · No phase

  Source: ClinicalTrials.gov
• 5 Nov 2026

  New in the registry

  Effects of Individualized Preferred and Higher Treadmill Walking Speeds Followed by Cognitive Training on Heart Rate Variability, Gait Performance, and Motor-Cognitive Function in Older Adults With Type 2 Diabetes: A Randomized Controlled Trial With 4-Week Retention Follow-up

  NCT07920510 · No phase · Thailand

  Source: ClinicalTrials.gov
• 5 Nov 2026

  New in the registry

  Fuling Yunhua Granules and Dihuang Baoyuan Granules in Adults With Type 2 Diabetes and Poor Glycemic Control Despite Lifestyle Intervention

  NCT07920640 · Phase 2 · China

  Source: ClinicalTrials.gov
• 5 Nov 2026

  Opened for recruitment

  Chiglitazar Added to SGLT-2 Inhibitors for Type 2 Diabetes

  NCT07580638 · No phase · China

  Source: ClinicalTrials.gov
• 5 Nov 2026

  New in the registry

  Pilates vs. Core Stabilization for Balance and Mobility in Elderly Type 2 Diabetics

  NCT07920653 · No phase

  Source: ClinicalTrials.gov
• 5 Nov 2026

  New in the registry

  Beta-2-Trace Protein in Diabetic Nephropathy

  NCT07919795 · No phase

  Source: ClinicalTrials.gov
• 5 Nov 2026

  Closed for recruitment

  Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release Tablets

  NCT07511010 · Phase 1 · China

  Source: ClinicalTrials.gov
• 5 Nov 2026

  New in the registry

  Continuous Glucose Monitoring Systems in People With Type 2 Diabetes Not Treated With Insulin

  NCT07919236 · No phase · Poland

  Source: ClinicalTrials.gov
• 5 Nov 2026

  New in the registry

  Inter-Arm Differences in Continuous Glucose Monitor Readings in Adults With Diabetes

  NCT07920341 · No phase · United States

  Source: ClinicalTrials.gov
• 5 Nov 2026

  Closed for recruitment

  Evaluating the Effectiveness of a Multi-level Health-Related Social Needs Initiative

  NCT06831162 · No phase · United States

  Source: ClinicalTrials.gov
• 5 Nov 2026

  Closed for recruitment

  Groceries Plus Multi-Component Lifestyle Intervention for Adults With Hypertension and Type 2 Diabetes

  NCT06921356 · No phase · United States

  Source: ClinicalTrials.gov
• 5 Nov 2026

  New in the registry

  Community Health Worker Nutrition Self-Management Support for Cardio-Kidney-Metabolic Health

  NCT07918508 · No phase · United States

  Source: ClinicalTrials.gov
• 26 Oct 2026

  Status changed: Recruiting → Not yet recruiting

  A Research Study to Check the Safety of NNC9836-0001 When Given to Healthy Participants and Participants With Type 2 Diabetes

  NCT07896109 · Phase 1 · Germany

  Source: ClinicalTrials.gov
• 10 Sept 2026

  Phase changed: Phase 1 → Phase 1/2

  A Three-part First-in-human Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB-UCN2 in Healthy Lean and Obese Participants and Participants With T2D

  NCT07702890 · Phase 1/2 · Germany

  Source: ClinicalTrials.gov
• 30 Sept 2026

  Opened for recruitment

  A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

  NCT07564414 · Phase 3 · Argentina, Austria, Australia, Belgium, Bulgaria, Canada

  Source: ClinicalTrials.gov
• 12 May 2026

  Phase changed: Phase 2 → Phase 3

  Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients

  NCT07581145 · Phase 3 · Denmark

  Source: ClinicalTrials.gov
• 13 Oct 2026

  Closed for recruitment

  A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)

  NCT07400653 · Phase 3 · Argentina, Bulgaria, Canada, Czechia, Germany, Spain

  Source: ClinicalTrials.gov
• 12 Mar 2026

  Status changed: Running, not recruiting → Not yet recruiting

  AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

  NCT07400107 · Phase 3 · Argentina, Bulgaria, Brazil, Germany, Croatia, Hungary

  Source: ClinicalTrials.gov
• 2 Jan 2026

  Opened for recruitment

  GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM

  NCT07314684 · Phase 4 · Italy

  Source: ClinicalTrials.gov
• 11 Aug 2026

  Opened for recruitment

  A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

  NCT07112339 · Phase 4 · Canada, Germany, Italy

  Source: ClinicalTrials.gov
• 22 Dec 2025

  Status changed: Recruiting → By invitation only

  Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study

  NCT06954090 · Phase 4 · Denmark, Spain

  Source: ClinicalTrials.gov
• 21 Apr 2026

  Status changed: Recruiting → By invitation only

  Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)

  NCT06845345 · Phase 4 · Netherlands

  Source: ClinicalTrials.gov
• 11 Mar 2026

  Opened for recruitment

  A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

  NCT06717698 · Phase 2 · Argentina, Australia, Bulgaria, Brazil, Czechia, Spain

  Source: ClinicalTrials.gov
• 25 Jul 2024

  Opened for recruitment

  Reducing Non-Alcoholic Steatohepatitis

  NCT06519448 · Phase 4 · Czechia

  Source: ClinicalTrials.gov
• 23 Oct 2026

  Status changed: Completed → Running, not recruiting

  A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight

  NCT06151964 · Phase 1/2 · Austria, Canada, Germany, Japan, Sweden

  Source: ClinicalTrials.gov
• 12 Dec 2025

  Closed for recruitment

  A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes

  NCT05433584 · Phase 4 · Argentina, Canada, Czechia, Germany, United Kingdom, Israel

  Source: ClinicalTrials.gov
• 9 Sept 2026

  Opened for recruitment

  Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes

  NCT05153070 · Phase 2 · France

  Source: ClinicalTrials.gov
• 3 Mar 2026

  Closed for recruitment

  SGLT2 Inhibition in Hemodialysis

  NCT05179668 · Phase 2 · Austria

  Source: ClinicalTrials.gov
• 1 Sept 2026

  Phase changed: Phase 2/3 → Phase 3

  A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes

  NCT04786262 · Phase 3 · Canada, Switzerland, Germany, France, United Kingdom, Italy

  Source: ClinicalTrials.gov
• 8 Jul 2026

  Status changed: Running, not recruiting → Completed

  A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

  NCT04255433 · Phase 3 · Argentina, Austria, Australia, Belgium, Brazil, Canada

  Source: ClinicalTrials.gov
• 14 Mar 2023

  Opened for recruitment

  NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients

  NCT02817360 · Phase 4 · Austria, Spain, United Kingdom, Netherlands, New Zealand

  Source: ClinicalTrials.gov
• 15 Dec 2024

  Status changed: Completed → Not yet recruiting

  SGLT2 Inhibition in Hemodialysis

  NCT05179668 · Phase 2 · Austria

  Source: ClinicalTrials.gov
• 8 Oct 2024

  Status changed: By invitation only → Not yet recruiting

  Reducing Non-Alcoholic Steatohepatitis

  NCT06519448 · Phase 4 · Czechia

  Source: ClinicalTrials.gov
• 31 Jul 2026

  Opened for recruitment

  A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)

  NCT07400653 · Phase 3 · Argentina, Bulgaria, Canada, Czechia, Germany, Spain

  Source: ClinicalTrials.gov
• 30 Jun 2026

  Closed for recruitment

  A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

  NCT06717698 · Phase 2 · Argentina, Australia, Bulgaria, Brazil, Czechia, Spain

  Source: ClinicalTrials.gov
• 17 Feb 2025

  Closed for recruitment

  NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients

  NCT02817360 · Phase 4 · Austria, Spain, United Kingdom, Netherlands, New Zealand

  Source: ClinicalTrials.gov
• 18 Aug 2026

  Opened for recruitment

  A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes

  NCT05433584 · Phase 4 · Argentina, Canada, Czechia, Germany, United Kingdom, Israel

  Source: ClinicalTrials.gov
• 4 Mar 2026

  Status changed: Recruiting → Not yet recruiting

  A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

  NCT07112339 · Phase 4 · Canada, Germany, Italy

  Source: ClinicalTrials.gov
• 25 Nov 2025

  Status changed: Recruiting → Not yet recruiting

  GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM

  NCT07314684 · Phase 4 · Italy

  Source: ClinicalTrials.gov
• 25 Aug 2026

  Closed for recruitment

  AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

  NCT07400107 · Phase 3 · Argentina, Bulgaria, Brazil, Germany, Croatia, Hungary

  Source: ClinicalTrials.gov
• 4 Aug 2026

  Closed for recruitment

  A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

  NCT07564414 · Phase 3 · Argentina, Austria, Australia, Belgium, Bulgaria, Canada

  Source: ClinicalTrials.gov
• 22 Oct 2026

  Opened for recruitment

  A Research Study to Check the Safety of NNC9836-0001 When Given to Healthy Participants and Participants With Type 2 Diabetes

  NCT07896109 · Phase 1 · Germany

  Source: ClinicalTrials.gov
• 18 Jun 2026

  Closed for recruitment

  Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes

  NCT05153070 · Phase 2 · France

  Source: ClinicalTrials.gov
• 4 Nov 2026

  New in the registry

  AI-Based Model for Predicting Type 2 Diabetes Risk Using Lifestyle Factors Among Senior Nursing Students

  NCT07916428 · No phase · Egypt

  Source: ClinicalTrials.gov
• 4 Nov 2026

  Opened for recruitment

  A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

  NCT07881458 · Phase 3 · Brazil, China, Germany, Spain, Japan, South Korea

  Source: ClinicalTrials.gov
• 4 Nov 2026

  New in the registry

  A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)

  NCT07915609 · Phase 3 · United States

  Source: ClinicalTrials.gov
• 4 Nov 2026

  Opened for recruitment

  AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes

  NCT07697391 · Phase 4 · China

  Source: ClinicalTrials.gov
• 4 Nov 2026

  New in the registry

  Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

  NCT07915596 · No phase · Bangladesh

  Source: ClinicalTrials.gov
• 4 Nov 2026

  Closed for recruitment

  Impact of Dual vs. Single Task Exercise on Cognitive Function, Balance, and Functionality in Type 2 Diabetes

  NCT06819371 · No phase

  Source: ClinicalTrials.gov
• 4 Nov 2026

  Opened for recruitment

  Clinical Decision Support for SGLT2i After AKI in Type 2 Diabetes

  NCT07868666 · No phase · United States

  Source: ClinicalTrials.gov
• 4 Nov 2026

  New in the registry

  A Nurse-Led Digital Coaching Program to Improve Blood Sugar Control in Adults With Type 2 Diabetes

  NCT07916584 · No phase · Bahrain

  Source: ClinicalTrials.gov
• 4 Nov 2026

  Closed for recruitment

  Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention

  NCT06055036 · No phase · United States

  Source: ClinicalTrials.gov
• 4 Nov 2026

  New in the registry

  Use and Acceptability of an AI-Assisted Health Application for Individuals Living With a Chronic Condition

  NCT07916753 · No phase · Switzerland

  Source: ClinicalTrials.gov
• 25 Jul 2024

  Phase changed: No phase → Phase 4

  Reducing Non-Alcoholic Steatohepatitis

  NCT06519448 · Phase 4 · Czechia

  Source: ClinicalTrials.gov
• 26 Feb 2025

  Phase changed: No phase → Phase 2

  Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes

  NCT05501483 · Phase 2 · Denmark, Sweden

  Source: ClinicalTrials.gov

New reviews, guidelines and randomised trials in PubMed

• 5 Nov 2026

  Randomised trial

  Effects of Multicomponent Training on Body Composition and Cardiorespiratory Fitness in Adults With Type 2 Diabetes: A Randomized Controlled Trial.

  Scandinavian journal of medicine & science in sports · PubMed

• 4 Nov 2026

  Randomised trial

  Effects and mechanisms of exercise timing on cognitive function in older type 2 diabetes mellitus patients with mild cognitive impairment: A magnetic resonance imaging-based randomized controlled trial protocol.

  PloS one · PubMed

• 3 Nov 2026

  Meta-analysis

  Effect of Exercise Interventions on Sarcopenia-Related Outcomes in Older Adults With Type 2 Diabetes: A Systematic Review and Meta-Analysis.

  Geriatrics & gerontology international · PubMed

• 2 Nov 2026

  Guideline

  [Continuous glucose monitoring in diabetes: Clinical practice guidelines for primary care from SEMERGEN, RedGDPS, semFYC, SEMG and FAECAP].

  Semergen · PubMed

• 2 Nov 2026

  Randomised trial

  Adjunctive neodymium-doped yttrium aluminum garnet laser therapy for periodontitis in type 2 diabetes: A randomized controlled trial.

  The Journal of international medical research · PubMed

• 1 Nov 2026

  Meta-analysis

  Effects of ginger intervention on anthropometric and body composition indices in patients with type 2 diabetes: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials.

  BMC complementary medicine and therapies · PubMed

• 1 Nov 2026

  Meta-analysis

  Severe Infection Outcomes With SGLT2 Versus DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Active-Comparator Meta-Analysis of Real-World Cohorts.

  Endocrinology, diabetes & metabolism · PubMed

• 1 Nov 2026

  Meta-analysis

  Effectiveness of Traditional Chinese Fitness Methods on Depressive Symptoms and Glycaemic Control in Patients With Type 2 Diabetes and Comorbid Depression: A Systematic Review and Meta-Analysis of Taijiquan and Baduanjin.

  Endocrinology, diabetes & metabolism · PubMed

• 31 Oct 2026

  Systematic review

  Glycemic control and weight loss benefits of fixed-ratio combinations of basal insulins and GLP1 receptor agonists in type 2 diabetes: A systematic review and network meta-analysis.

  Endocrine · PubMed

• 31 Oct 2026

  Meta-analysis

  Elevated Lipoprotein(a) Predicts Recurrent Myocardial Infarction in Diabetic Patients Following Acute Coronary Syndromes.

  Clinical cardiology · PubMed

• 31 Oct 2026

  Systematic review

  Effects of faecal microbiota transplantation on glycaemic outcomes in adults with metabolic disorders: a systematic review and meta-analysis of randomised controlled trials.

  Frontiers in medicine · PubMed

• 31 Oct 2026

  Meta-analysis

  Association of remnant cholesterol with kidney outcomes in adults with type 2 diabetes: a systematic review and meta-analysis.

  Frontiers in endocrinology · PubMed

• 31 Oct 2026

  Randomised trial

  Effects of morning versus evening exercise on vascular function in older adults with type 2 diabetes: a randomised controlled trial.

  Frontiers in endocrinology · PubMed

• 31 Oct 2026

  Meta-analysis

  Global burden of type 2 diabetes attributable to SARS-CoV-2 infection.

  Frontiers in immunology · PubMed

Results card

Trials that finished or stopped in the last 3 years, with the reason the registry gives and linked publications.

• No phaseEnded 29 Oct 2026

  Completed731 participants

  NCT07079085

  Safety Evaluation of Pueraria Lobata Radix in Specific Consumption Scenarios for Type 2 Diabetes

  Registry record

• No phaseEnded 28 Oct 2026

  Completed348 participants

  NCT06055036

  Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention

  Registry record

• Phase 1Ended 25 Oct 2026

  Completed28 participants

  NCT07511010

  Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release Tablets

  Registry record

• No phaseEnded 18 Oct 2026

  Completed124 participants

  NCT06907329

  The Impact of Nicotinamide Mononucleotide Sustained-release Tablets on Immunosenescence and Metabolism in Middle-aged and Elderly Individuals With Metabolic Disorders.

  Registry record

• Phase 1Ended 13 Oct 2026

  Completed20 participants

  NCT06592261

  Graded Insulin Suppression Test P&F

  Registry record

• Phase 1Ended 7 Oct 2026

  Completed36 participants

  NCT07872358

  Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCl25 mg/5 mg/1000 mg Extended Release Tablet Versus Trijardy® XR 25 mg/5 mg/1000 mg Extended- Release Tablets

  Registry record

• Phase 2Ended 2 Oct 2026

  Completed447 participants

  NCT06628362

  A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

  Registry record

• No phaseEnded 2 Oct 2026

  Completed16 participants

  NCT06999356

  Salud Diabetes: A Pilot Study Comparing Lifestyle Interventions and Real-Time Continuous Glucose Monitoring

  Registry record

• No phaseEnded 1 Oct 2026

  Completed100 participants

  NCT07839546

  Adherence to Clinical Guidelines for Management of Patients With Type 2 Diabetes Mellitus and Obesity

  Registry record

• Phase 1/2Ended 29 Sept 2026

  Completed201 participants

  NCT06924320

  A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes

  • Long-acting amylin-related peptides as therapies for obesity and type 2 diabetes. · Peptides, 2026
  Registry record

• No phaseEnded 28 Sept 2026

  Completed3392 participants

  NCT07424430

  Real-world Canadian Retrospective Study Evaluating Longitudinal Semaglutide Use on Cardio-Kidney-Metabolic Outcomes

  Registry record

• No phaseEnded 25 Sept 2026

  Completed44 participants

  NCT06384313

  Butyrate-enriched Triglyceride and Diabetes Prevention

  Registry record

• Phase 2Ended 18 Sept 2026

  Completed58 participants

  NCT07400588

  Aleniglipron Phase 2 in Type 2 Diabetes Mellitus

  Registry record

• No phaseEnded 17 Sept 2026

  Completed13 participants

  NCT06790225

  Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)

  Registry record

• Phase 2Ended 14 Sept 2026

  Completed367 participants

  NCT06603571

  A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  Registry record

• Phase 1Ended 2 Sept 2026

  Completed53 participants

  NCT07242469

  A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)

  Registry record

• No phaseEnded 1 Sept 2026

  Completed11 participants

  NCT06572306

  Pharmacist-led Continuous Glucose Monitoring

  Registry record

• No phaseEnded 31 Aug 2026

  Completed43 participants

  NCT07778121

  Screening for Obstructive Sleep Apnea in High-risk Patients in a Danish Rural Population: A Pilot Feasibility Study

  Registry record

• No phaseEnded 30 Aug 2026

  Completed29 participants

  NCT07802275

  Postprandial Glucose Kinetics After Carbohydrate Restriction

  Registry record

• Phase 1Ended 30 Aug 2026

  Completed32 participants

  NCT07349381

  A Food-Effect Study of CX11 in Healthy Participants

  Registry record

• No phaseEnded 30 Aug 2026

  Completed304 participants

  NCT05288452

  Food Delivery, Remote Monitoring, and Coaching-Enhanced Education for Optimized Diabetes Management (FREEDOM)

  • Rationale and design of the FREEDOM study: A hybrid type 1 optimization-implementation trial to improve type 2 diabetes management in primary care. · Contemporary clinical trials, 2026
  Registry record

• No phaseEnded 30 Aug 2026

  Completed1149 participants

  NCT07840807

  Traditional Chinese Medicine Fasting Therapy, Ketone Levels, and Metabolic Improvements

  Registry record

• No phaseEnded 28 Aug 2026

  Completed44 participants

  NCT07126587

  Healthy Living Anson Study

  Registry record

• No phaseEnded 28 Aug 2026

  Completed19 participants

  NCT06574035

  Michigan Men's Diabetes Project III(MenDIII): Mind and Motion

  Registry record

• Phase 4Ended 28 Aug 2026

  Completed23 participants

  NCT05757713

  Teplizumab in Pediatric Stage 2 Type 1 Diabetes

  • Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes. · Diabetologia, 2026
  Registry record

• No phaseEnded 27 Aug 2026

  Completed60 participants

  NCT07876180

  Effects of High-Intensity Interval Training and Exercise Snacking on Glycemic Control and Cardiorespiratory Fitness in Adults With Type 2 Diabetes Mellitus

  Registry record

• Phase 4Ended 24 Aug 2026

  Completed80 participants

  2025-521748-39-00

  SGLT-2i, Heart, Improvement of Cardiovascular Autonomic Neuropathy

  Registry record

• No phaseEnded 20 Aug 2026

  Completed100000 participants

  NCT07719621

  Evaluation of the Risk of Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

  Registry record

• No phaseEnded 19 Aug 2026

  Completed46 participants

  NCT07256613

  Non-surgical Periodontal Therapy and Kidney Outcomes in Type 2 Diabetes Mellitus

  Registry record

• No phaseEnded 18 Aug 2026

  Completed6928 participants

  NCT06831162

  Evaluating the Effectiveness of a Multi-level Health-Related Social Needs Initiative

  Registry record

• No phaseEnded 17 Aug 2026

  Completed13 participants

  NCT07295600

  Postprandial Effect of Isocaloric Challenge Meals Enriched With Indigenous Fruits and Vegetables on Glucose Metabolism in Individuals With Type 2 Diabetes in Wakiso District, Uganda

  Registry record

• No phaseEnded 15 Aug 2026

  Completed36 participants

  NCT06819371

  Impact of Dual vs. Single Task Exercise on Cognitive Function, Balance, and Functionality in Type 2 Diabetes

  Registry record

• No phaseEnded 15 Aug 2026

  Completed100 participants

  NCT07660081

  Effects of Acetyl L-Carnitine Supplementation on Clinical, Metabolic and Inflammatory Symptoms in Obese, Diabetic, Postmenopausal Women With Osteoarthritis

  Registry record

• No phaseEnded 14 Aug 2026

  Completed35 participants

  NCT07005362

  Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D

  Registry record

• Phase 1Ended 14 Aug 2026

  Completed14 participants

  NCT05601583

  Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment

  Registry record

• Phase 2Ended 13 Aug 2026

  Completed221 participants

  NCT06926842

  Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

  Registry record

• Phase 1Ended 13 Aug 2026

  Completed20 participants

  NCT07313813

  A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes Mellitus

  Registry record

• Phase 2Ended 10 Aug 2026

  Completed100 participants

  NCT07321678

  A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus

  Registry record

• No phaseEnded 10 Aug 2026

  Completed116 participants

  NCT06457139

  Preventing T2DM After GDM With Immediate Postpartum Screening

  Registry record

• Phase 1Ended 10 Aug 2026

  Completed162 participants

  NCT07801326

  A Study to Evaluate Different Administration Conditions and the Food Effect of MWN109 Tablets in Chinese Participants

  Registry record

• No phaseEnded 7 Aug 2026

  Completed59 participants

  NCT07675161

  MiniMed Fit Payload Wear Pediatric Study

  Registry record

• Phase 1Ended 7 Aug 2026

  Completed14 participants

  2025-522662-67-00

  A Trial to Evaluate Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Insulin GZR4 Compared with Insulin Degludec and Insulin Icodec in Participants with Type 2 Diabetes

  Registry record

• Phase 2Ended 5 Aug 2026

  Completed142 participants

  NCT06797869

  A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy

  Registry record

• Phase 1Ended 5 Aug 2026

  Completed219 participants

  NCT06945419

  A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes

  Registry record

• Phase 3Ended 4 Aug 2026

  Completed267 participants

  NCT07271251

  A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 Diabetes

  Registry record

• No phaseEnded 3 Aug 2026

  Completed64 participants

  NCT07519265

  Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets

  Registry record

• No phaseEnded 1 Aug 2026

  Completed40 participants

  NCT06900946

  Evaluation of the Effects of Gluten Free Diet on Clinical Symptoms and Glycemic Index in Type 2 Diabetic Patients With Non-celiac Gluten Sensitivity

  Registry record

• No phaseEnded 31 Jul 2026

  Completed58 participants

  NCT05768958

  Hedonic and Homeostatic Appetite Control in Obesity and Type 2 Diabetes in the Context of Meal and Exercise Timing

  • Effects of exercise and exercise timing on energy intake and appetite control: a randomised crossover trial in people with overweight or obesity with and without type 2 diabetes. · EBioMedicine, 2026
  Registry record

• Phase 2Ended 30 Jul 2026

  Completed134 participants

  NCT05536804

  A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

  Registry record

• Phase 4Ended 26 Jul 2026

  Completed70 participants

  NCT06205030

  Efficacy of NOSHINtrial in Diabetic Patients

  Registry record

• Phase 3Ended 18 Jul 2026

  Completed884 participants

  NCT06649344

  A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes

  Registry record

• No phaseEnded 15 Jul 2026

  Completed102 participants

  NCT07847593

  Probiotics in Obese Patients Treated With Semaglutide

  Registry record

• Phase 3Ended 9 Jul 2026

  Completed1023 participants

  NCT06534411

  A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

  Registry record

• No phaseEnded 9 Jul 2026

  Completed230000 participants

  NCT03363464

  Comparative Effectiveness of Empagliflozin in the US

  Registry record

• No phaseEnded 8 Jul 2026

  Completed214 participants

  NCT04831385

  The Impact of Cognitive Behavioral Therapy for Insomnia (CBT-I) on Glycemic Control in Older Type 2 Diabetes (T2D) Comorbid With Insomnia

  Registry record

• Phase 1Ended 2 Jul 2026

  Completed32 participants

  NCT07444424

  A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy Participants

  Registry record

• No phaseEnded 1 Jul 2026

  Completed30 participants

  NCT07801131

  Ultrasonographic Evaluation of Talar Cartilage Thickness in Patients With Diabetic Polyneuropathy

  Registry record

• No phaseEnded 1 Jul 2026

  Completed87 participants

  NCT04536480

  Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)

  Registry record

• Phase 1Ended 1 Jul 2026

  Completed36 participants

  NCT07691203

  Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCl 25 mg/5 mg/1000 mg Extended Release Tablet Versus Trijardy® XR 25 mg/5 mg/1000 mg Extended- Release Tablets

  Registry record

• Phase 1Ended 1 Jul 2026

  Completed40 participants

  NCT07694115

  Bioequivalence Study to Compare Empagliflozin/ Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg

  Registry record

Not medical advice. fetched 6 Nov 2026